Endometriosis Treatment
Endometriosis Treatment
Treatment here is organised around two separate lines, because the same drug and the same operation do not answer both. The pain line can usually be started on a clinical diagnosis, before any operation confirms it, and it works mainly by suppressing the cycle that drives the disease. The fertility line is assessed by its own examinations and treated on its own indications. Surgery belongs to both, but it is not the first answer to either, and recurrence afterwards is the expected behaviour of the condition rather than a failure — which is why what happens after an operation is planned before it, not after.
Why treatment is organised as two lines rather than one
The most common reason a plan fails is that it was written for one line and applied to the other:
- The pain line is treated on the clinical picture. Where the history is typical and other causes have been considered, treatment for pain can begin before any operation confirms the diagnosis, because waiting has its own cost.
- The fertility line is treated on the fertility assessment. Ovarian reserve, ovulation and tubal patency are its subject, and none of them is answered by the pain history or by imaging of the disease.
- Some treatments work on one line and not the other, and some work against each other. Methods that suppress the cycle control the pain and prevent pregnancy; ovulation induction and assisted reproduction aim at a pregnancy and do not treat the pain.
- Improving one does not automatically improve the other. A woman whose pain has been controlled may still need fertility treatment, and a woman who has conceived may still need the pain managed afterwards.
Why naming the lines is part of the treatment. A plan without this distinction tends to treat whichever line is easier to measure and to leave the other until it becomes urgent. Writing down which line is being treated, and when the other is reviewed, is what keeps both in view.
Medical treatment for the pain
Medical treatment works by suppressing or altering the cycle that drives the disease, and it is usually the first step:
- Combined hormonal contraception. Taken continuously or with extended cycling rather than with a monthly break, it reduces the bleeding and the pain that follow the cycle. It is often the first treatment, where there is no contraindication and no pregnancy is wanted.
- Progestogens, by mouth, by injection or released inside the womb. These are used where an oestrogen-containing method is unsuitable, not tolerated or not wanted, and they also reduce bleeding.
- GnRH agonists and antagonists for a defined period. These suppress the cycle more completely and are used where other measures have not controlled the symptoms. They are given as a course with a time limit set in advance, and hormone add-back is used where it is needed to protect bone.
- Analgesia planned around the cycle rather than taken reactively. Pain that is expected can be pre-empted, and anti-inflammatory drugs taken before the pain peaks work better than the same drugs chased after it.
- What medical treatment does not do. It does not remove the disease, and it does not improve fertility. Its effect lasts while it is taken, which is why the review date and the duration are part of the prescription rather than an afterthought.
Why medical treatment is tried before surgery in most cases. It is reversible, it can be started on a clinical diagnosis, and how the pain responds to it is itself useful information. It also avoids exposing a woman to the risks of an operation before it is known whether a simpler measure would have controlled the symptoms.
What surgery does, and what it does not
Surgery is the treatment of the disease itself rather than of its symptoms, and its role is specific:
- Excision or ablation of the lesions. This is the surgical treatment of the disease, and it is performed at laparoscopy. Excision removes the lesion; ablation destroys it in place. Which is used depends on the site, the depth and the operator, and both are established techniques.
- Division of adhesions. Where tethering is distorting anatomy and explains the symptoms, dividing it can restore mobility and relieve the pain that comes from pulling rather than from active disease.
- Surgery for deep disease is a different undertaking. Where the bowel, the bladder or the ureter is involved, the operation is planned with the disciplines that would be needed if those organs are opened, and the threshold for operating is higher rather than lower.
- Removing an ovary is not a routine part of treating this condition. Radical surgery — removing the womb and both ovaries — is reserved for severe symptoms that have not responded to everything else, in someone who does not want to conceive. It is not a treatment for moderate disease.
- Surgery does not cure the condition. It removes what is visible and what can be removed safely. Disease that is microscopic or in a position that cannot be safely cleared may remain, and new disease can develop.
Why the effect on the ovary is discussed beforehand. Removing an endometrioma from an ovary also removes some normal ovarian tissue, and that reserve does not return. Where a woman may want to conceive later, this is weighed before the operation rather than discovered afterwards — which is one reason more surgery is not automatically better surgery.
What happens after an operation, and why recurrence is expected
Recurrence is the part of surgery that is most often not explained in advance:
- Recurrence is the expected behaviour of the disease. Symptoms returning after an operation is not evidence that the surgery was done badly. It reflects the nature of a condition that responds to the cycle and can develop new lesions.
- Suppression after surgery is often planned in advance. Where pain has been the main problem, hormonal treatment is frequently started or resumed after the operation, so that the cycle that drives the disease is suppressed while healing takes place.
- The fertility line is not changed by the operation alone. Where a pregnancy is wanted, the fertility assessment and the timing of any treatment are decided on their own evidence, not on the assumption that an operation has resolved them.
- Repeat surgery is a decision with a cost. Each further operation carries its own risks and its own effect on the ovary, so a second operation is considered against what it will achieve rather than as a default response to returning pain.
Why this is explained before the operation rather than after. A woman who has been told that surgery will remove the disease will read its return as failure and may avoid further treatment. A woman who has been told that recurrence is expected reads it as the signal to return, which is what makes the follow-up plan work.
The fertility line, and how it is planned
This line is assessed and treated on its own indications, and it runs in parallel with the pain line rather than after it:
- It is assessed by its own examinations. Ovarian reserve, ovulation, and tubal patency where relevant, together with the partner’s assessment, because the fertility question has more than one contributor.
- Surgery can help conception where anatomy is the obstacle. Adhesions that distort the relationship between the ovary and the tube, or an endometrioma that is large enough to interfere, are situations in which an operation can change what is possible.
- Assisted reproduction is used on its own indications. Where the tubes are affected, where the reserve is reduced, or where other factors are present, treatment is planned on those grounds rather than as a treatment for the disease.
- Treatments that suppress the cycle are paused when a pregnancy is wanted. The pain line and the fertility line are sequenced deliberately at that point rather than run together.
- What is not promised. No plan can promise a pregnancy, and no operation can guarantee it. What the assessment can do is establish where the obstacles are and which of them can be acted on.
Why the two lines are discussed in one consultation. The decision about which comes first depends on both, and it changes if the pain becomes unmanageable or if the fertility assessment finds something unexpected. Planning them together is what allows the sequence to be adjusted deliberately rather than by default.
The plan, and what continues long term
What holds this together is a written plan with named decisions and named review points:
- Which line is being treated now, and which is being watched. Written down, with the reason, so that a change of clinician does not change the plan by accident.
- The duration of any hormonal course, and its review date. A treatment intended as a course should not become indefinite by default, and a treatment intended as long-term should be reviewed deliberately.
- The triggers that would change the approach. Pain that becomes continuous rather than cyclical, new bowel or bladder symptoms, a change in fertility plans, or the failure of a treatment that was expected to work.
- What continues after the presenting problem is settled. Bone protection where the cycle has been suppressed for a prolonged period, the ovarian reserve where surgery has taken place, and the pain line again after a pregnancy.
Why a written plan matters more here than in most conditions. This is a long-term condition with two lines, several specialties and a natural tendency to fluctuate. The plan is what keeps the treatment attached to a decision rather than to the last symptom reported.